WIL Group Connects Global Markets Through API Trading and CDMO Excellence
Exhibitor: WENDY INTERNATIONAL LTD
Date: 2026-03-31
Booth No.: N/A
TAICHUNG, TAIWAN – In the rapidly evolving global biopharmaceutical landscape, Taichung-based WIL Group (Wendy International Co., Ltd.) is steadily expanding its footprint across Asia’s biotech raw materials and manufacturing sectors. From active pharmaceutical ingredients (APIs) to health supplements, and from raw material sourcing to integrated contract manufacturing, WIL Group is crafting a comprehensive industry map encompassing R&D, production, regulatory compliance, and distribution.
Bridging the Asian Biotech Blueprint
Wendy Lu, founder of WIL Group, emphasizes that the strategic choice to establish roots in Singapore while maintaining a strong presence in Taiwan allows the group to leverage Singapore’s resource integration and Taiwan’s manufacturing prowess. "We aim to be the 'Bridge of the Asian Raw Material Supply Chain,'" says Lu. "We believe quality and integrity are the bedrock of longevity. Helping our clients succeed is our ultimate responsibility."
Stringent Quality Control: Ensuring Safety at the Source
WIL Group specializes in providing Active Pharmaceutical Ingredients (APIs) and Excipients that meet the rigorous standards of pharmaceutical manufacturers. To address the rising demand for natural health products, the company has expanded into natural essential oils, botanical extracts, and functional health food ingredients.
The group meticulously selects global partners with GMP, FDA, and ISO certifications. Combined with multi-layered laboratory testing and regulatory audits, WIL Group ensures every batch complies with international standards, upholding its core value of "Quality First, Integrity Always."
Integrated CDMO Services: Bridging R&D and Marketization
Beyond supply, WIL Group actively develops its CMO and CDMO (Contract Development and Manufacturing Organization) capabilities. By providing integrated solutions—from formulation R&D and product design to packaging and regulatory filing—WIL Group helps clients meet market demands for efficiency and quality.
For startups and SMEs, these services are vital. Leveraging a professional team with pharmacist backgrounds, WIL Group assists clients in shortening the "Lab-to-Market" cycle, simplifying complex processes to enhance market competitiveness.
Dual-Hub Strategy: Taiwan Roots, Singapore Reach
To deepen its service capacity in the Asia-Pacific, WIL Group recently established Wendy Pharma Pte. Ltd. in Singapore. Functioning as a regional outpost and international logistics hub, the Singapore office enhances supply efficiency and strengthens ties with local pharmaceutical plants, health brands, and OEM manufacturers. This realizes the group’s "Dual-Hub Strategy": Taiwan as the R&D foundation and Singapore as the international gateway.
Diverse Product Portfolio: Meeting Modern Health Trends
WIL Group offers a professional supply system across several core domains:
APIs: High-quality ingredients for cardiovascular, metabolic, and psychiatric medications.
Excipients: High-purity binders, disintegrants, and emulsifiers for dosage stability.
Fine Chemicals & Impurities: Providing reference standards and high-purity chemicals for precise quality control and regulatory filing.
Finished Products: OEM/ODM services for tablets, capsules, and oral liquids.
Botanicals & Supplements: Pesticide-free plant extracts and functional ingredients targeting gut health, sleep management, and anti-oxidation.
Featured Product Highlights
AMPS (Acrylamido Methyl Propane Sulfonic Acid): A versatile rheology modifier/gelling agent for personal care. It remains stable in >70% alcohol formulas (where Carbomers often fail) and provides a silky, non-sticky skin feel.
Effervescent Tablets: Fully customizable OEM services for flavor and ingredients, including the best-selling Vitamin D3+Zinc+C formula.
Party Pal: A sugar-free orodispersible granule using ORAMELT™ technology. It features C3 CURA™ to significantly enhance the bioavailability of Curcuminoids for rapid recovery.
Low-Molecular Apple Oligosaccharide: A plant-based, additive-free supplement refined via three patented thermal processes to ensure high absorption of apple polyphenols and pectin.
For more information, please visit: www.WIL.com.tw
Email: sales@wil.com.tw
Tel: +886-4-26880838
More Exhibitor's Press Release
- WIL Group provides high-quality API; charitable associations spread love and care. WENDY INTERNATIONAL LTD / 2026-03-31
- Mycenax Ignites Long-Term Growth with Commercial Manufacturing and Strategic Japan Joint Venture MYCENAX BIOTECH INC. / 2026-03-31
- Formosa Pharma and Rxilient Inc Deal to Commercialize APP13007 for ASEAN markets FORMOSA PHARMACEUTICALS , INC / 2026-03-27
- Formosa Pharma Partners with Samil to Commercialize Ophthalmic Treatment for Ocular Surgery FORMOSA PHARMACEUTICALS , INC / 2026-03-27
- Formosa Pharma Licenses Ophthalmic Suspension to Arrotex for Post-Surgery Pain & Inflammation FORMOSA PHARMACEUTICALS , INC / 2026-03-27
- Yenchen Machinery Started Being Enwave Optronics Exclusive Agent PAT(Process Analytical Technology) YENCHEN MACHINERY CO., LTD. / 2026-03-27
- Yenchen acts as agent of NFA Automatic Tablet & Capsule Inspection Machine YENCHEN MACHINERY CO., LTD. / 2026-03-27
- Taiwan’s 45-Year Leading Brand in Vacuum Emulsify Mixing Equipment — MINOGA INDUSTRIAL CO., LTD. MINOGA INDUSTRIAL CO., LTD. / 2026-03-26